Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity.
about
Pharmacotherapy for Irritable Bowel Syndrome.Gut Microbiota-Based Therapies for Irritable Bowel Syndrome.Rifaximin Re-treatment in Patients with Irritable Bowel Syndrome: Feels Like the First Time?Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective.Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017.Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin
P2860
Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Repeat Rifaximin for Irritable ...... robial Antibiotic Sensitivity.
@en
type
label
Repeat Rifaximin for Irritable ...... robial Antibiotic Sensitivity.
@en
prefLabel
Repeat Rifaximin for Irritable ...... robial Antibiotic Sensitivity.
@en
P2093
P2860
P1476
Repeat Rifaximin for Irritable ...... robial Antibiotic Sensitivity.
@en
P2093
P2860
P2888
P356
10.1007/S10620-017-4598-7
P577
2017-06-06T00:00:00Z
P6179
1085886405